Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,653,222
-$4,246,907 QoQ
Shares Held
853,304
-13.0% QoQ
Ownership
0.956%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 242 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. SNDX ranks #29 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in SNDX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,653,222 | 853,304 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $22,900,129 | 980,314 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $19,454,712 | 925,974 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,585,997 | 558,076 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,159,352 | 230,577 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $4,636,896 | 377,444 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $862,114 | 65,213 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $489,315 | 25,419 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $559,914 | 27,273 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,266,540 | 53,216 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $775,842 | 35,902 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $356,785 | 24,572 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $450,790 | 21,538 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $490,575 | 23,228 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $640,703 | 25,175 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $526,953 | 21,929 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $680,287 | 35,358 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $412,792 | 23,751 | Shares | Defined | 2022-05-16 | |
| 2021-03-31 | $417,684 | 18,680 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $666,377 | 29,963 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $633,720 | 42,935 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $664,054 | 44,808 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $117,697 | 10,729 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||